XML 46 R14.htm IDEA: XBRL DOCUMENT v3.3.1.900
Derivative Instruments
3 Months Ended
Mar. 31, 2016
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Derivative Instruments
Derivative Instruments
Foreign Currency Forward Contracts - Hedging Instruments
Due to the global nature of our operations, portions of our revenues and operating expenses are recorded in currencies other than the U.S. dollar. The value of revenues and operating expenses measured in U.S. dollars is therefore subject to changes in foreign currency exchange rates. In order to mitigate these changes we use foreign currency forward contracts to lock in exchange rates associated with a portion of our forecasted international revenues and operating expenses.
Foreign currency forward contracts in effect as of March 31, 2016 and December 31, 2015 had durations of 1 to 21 months and 1 to 18 months, respectively. These contracts have been designated as cash flow hedges and accordingly, to the extent effective, any unrealized gains or losses on these foreign currency forward contracts are reported in accumulated other comprehensive income (loss) (referred to as AOCI in the tables below). Realized gains and losses for the effective portion of such contracts are recognized in revenue when the sale of product in the currency being hedged is recognized and, beginning in the fourth quarter 2015, in operating expenses when the expense in the currency being hedged is recorded. To the extent ineffective, hedge transaction gains and losses are reported in other income (expense), net.
The notional value of foreign currency forward contracts that were entered into to hedge forecasted revenues and operating expenses is summarized as follows:
 
Notional Amount
Foreign Currency: (In millions)
As of
March 31,
2016
 
As of
December 31,
2015
Euro
$
1,251.3

 
$
945.5

Swiss francs
65.5

 
80.8

Canadian dollar
58.3

 
76.7

Total foreign currency forward contracts
$
1,375.1

 
$
1,103.0


The portion of the fair value of these foreign currency forward contracts that was included in accumulated other comprehensive income (loss) in total equity reflected net losses of $46.0 million and net gains of $1.8 million as of March 31, 2016 and December 31, 2015, respectively. We expect all contracts to be settled over the next 21 months and any amounts in accumulated other comprehensive income (loss) to be reported as an adjustment to revenue or operating expense. We consider the impact of our and our counterparties’ credit risk on the fair value of the contracts as well as the ability of each party to execute its contractual obligations. As of March 31, 2016 and December 31, 2015, credit risk did not change the fair value of our foreign currency forward contracts.
The following table summarizes the effect of foreign currency forward contracts designated as hedging instruments on our condensed consolidated statements of income:
For the Three Months Ended March 31,
Net Gains/(Losses)
Reclassified from AOCI into Operating Income
(Effective Portion)
 
Net Gains/(Losses)
Recognized into Net Income
(Ineffective Portion)
Location
 
2016
 
2015
 
Location
 
2016
 
2015
Revenue
 
$
8.8

 
$
35.0

 
Other income (expense)
 
$
1.9

 
$
2.2

Operating expenses
 
$
(0.1
)
 
$

 
Other income (expense)
 
$
(0.3
)
 
$


Interest Rate Contracts - Hedging Instruments
We have entered into interest rate swap contracts on certain borrowing transactions to manage our exposure to interest rate changes.
In connection with the issuance of our 2.90% Senior Notes, we entered into interest rate swaps with an aggregate notional amount of $675.0 million, which expire on September 15, 2020. The interest rate swap contracts are designated as hedges of the fair value changes in the 2.90% Senior Notes attributable to changes in interest rates. Since the specific terms and notional amount of the swaps match the debt being hedged, it is assumed to be a highly effective hedge and all changes in the fair value of the swaps are recorded as a component of the 2.90% Senior Notes with no net impact recorded in income. Any net interest payments made or received on the interest rate swap contracts are recognized as a component of interest expense in our condensed consolidated statements of income.
Foreign Currency Forward Contracts - Other Derivatives
We also enter into other foreign currency forward contracts, usually with one month durations, to mitigate the foreign currency risk related to certain balance sheet positions. We have not elected hedge accounting for these transactions.
The aggregate notional amount of these outstanding foreign currency contracts was $680.8 million and $721.0 million as of March 31, 2016 and December 31, 2015, respectively. A net gain of $2.4 million related to these contracts was recognized as a component of other income (expense), net, for three months ended March 31, 2016, as compared to a net loss of $9.7 million, in the prior year comparative period.
Summary of Derivatives
While certain of our derivatives are subject to netting arrangements with our counterparties, we do not offset derivative assets and liabilities in our condensed consolidated balance sheets.
The following table summarizes the fair value and presentation in our condensed consolidated balance sheets of our outstanding derivatives including those designated as hedging instruments:
 
 
Fair Value
(In millions)
Balance Sheet Location
As of March 31, 2016
Hedging Instruments:
 
 
Asset derivatives
Other current assets
$
1.8

 
Investments and other assets
$
12.8

Liability derivatives
Accrued expenses and other
$
35.0

 
Other long-term liabilities
$
7.1

Other Derivatives:
 
 
Asset derivatives
Other current assets
$
16.0

Liability derivatives
Accrued expenses and other
$
4.5

 
 
 
 
 
Fair Value
(In millions)
Balance Sheet Location
As of December 31, 2015
Hedging Instruments:
 
 
Asset derivatives
Other current assets
$
16.6

 
Investments and other assets
$
0.3

Liability derivatives
Accrued expenses and other
$
10.2

 
Other long-term liabilities
$
2.5

Other Derivatives:
 
 
Asset derivatives
Other current assets
$
10.3

Liability derivatives
Accrued expenses and other
$
2.0